THERMO FISHER SCIENTIFIC INC.

For the period ended Jun 27, 2026. Filed Jul 31, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 27, 2026 · Filed Jul 31, 2026

TMO$718.20-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Comprehensive Income

	Three months ended		Six months ended
	June 27,	June 28,	June 27,	June 28,
(In millions)	2026	2025	2026	2025
Comprehensive income/(loss)
Net income	$1,741	1,618	$3,397	$3,130
Other comprehensive income/(loss):
Cumulative translation adjustment:
Cumulative translation adjustment (net of tax provision (benefit) of $(41), $(207), $(14), and $(414))	39	(447)	(19)	(87)
Unrealized gains/(losses) on hedging instruments:
Reclassification adjustment for losses included in net income (net of tax (provision) benefit of $0, $0, $0, and $0)	1	1	1	1
Pension and other postretirement benefit liability adjustments:
Pension and other postretirement benefit liability adjustments arising during the period (net of tax (provision) benefit of $0, $3, $(1), and $4)	—	(8)	2	(11)
Amortization of net loss included in net periodic pension cost (net of tax (provision) benefit of $0, $1, $1 and $1)	1	3	2	4
Total other comprehensive income/(loss)	41	(451)	(14)	(93)
Comprehensive income/(loss)	1,782	1,168	3,383	3,037
Less: comprehensive income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest	9	4	8	12
Comprehensive income attributable to Thermo Fisher Scientific Inc.	$1,773	$1,164	$3,375	$3,025

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.